Humira Buyers Say AbbVie 'Contorting' Actavis At 7th Circ.
By Bryan Koenig · February 2, 2021, 9:34 PM EST
Humira buyers continued to press the Seventh Circuit on Monday to revive their suit accusing AbbVie of employing a "patent thicket" and other tactics to insulate its blockbuster immunosuppressant from competition,...
To view the full article, register now.